Free. We’ll email you when a new paper cites this one or any other paper you follow on JClub — at most one email a day. Every email has a one-tap unsubscribe.
Empirical valganciclovir in infants aged 28–365 days hospitalized with severe HIV-associated pneumonia is linked to lower day-15 mortality (rate ratio 0·81, 95% CI 0·61–1·08).
Pyr01 selectively eliminates HIV-1-infected primary human monocyte-derived macrophages with an EC50 of ~0.36 μM, while the inactive analog Pyr02 shows minimal activity.
In the US HIV care and prevention system, only 69% of diagnosed people with HIV are virally suppressed despite >$29 billion in annual treatment spending, linked in part to poverty.